David Apelian

David Apelian

Directeur Général chez EIGER BIOPHARMACEUTICALS
61 ans
Health Technology
Consumer Services

Profil

Dr. David Apelian is a Chief Executive Officer at Theolytics Ltd. and a Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. He is on the Board of Directors at Eiger BioPharmaceuticals, Inc. Dr. Apelian was previously employed as a Chief Executive Officer & Director by BlueSphere Bio, Inc., a Chief Medical Officer & Executive Vice President by Achillion Pharmaceuticals, Inc., a Chief Medical Officer, SVP-Research & Development by GlobeImmune, Inc., a Clinical Director-Infectious Diseases Group by Bristol Myers Squibb Co., a Clinical Director-Hepatology Department by Schering-Plough Corp., and a Vice President by Wyeth Pharmaceuticals LLC.
He received his undergraduate degree from Rutgers State University of New Jersey, an MBA from Quinnipiac University, a doctorate degree from the University of Medicine & Dentistry of New Jersey and a doctorate degree from Rutgers State University of New Jersey.

Postes actifs de David Apelian

SociétésPosteDébut
EIGER BIOPHARMACEUTICALS Directeur Général 15/12/2022
Directeur Général 17/12/2024

Anciens postes connus de David Apelian

SociétésPosteFin
Directeur Général 04/10/2022
ACHILLION PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 28/12/2017
GLOBEIMMUNE, INC. Directeur Technique/Scientifique/R&D 01/01/2013
BRISTOL-MYERS SQUIBB COMPANY Directeur Technique/Scientifique/R&D -
Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de David Apelian

Formation de David Apelian

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Apelian
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT